Article Details

Incyte's (INCY) Lymphoma Drug Obtains Positive CHMP Opinion

Retrieved on: 2021-06-28 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

Incyte's (INCY) Lymphoma Drug Obtains Positive CHMP Opinion. View article details on hiswai:

Excerpt

Tafasitamab is a humanized Fc-modified cytolytic CD19 targeting monoclonal antibodies. It is marketed under the brand name Monjuvi in the United ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up